Biodesix
BDSX
46 hedge funds and large institutions have $85.6M invested in Biodesix in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 8 closing their positions.
14% more capital invested
Capital invested by funds: $75.3M → $85.6M (+$10.3M)
0.08% more ownership
Funds ownership: 0.71% → 0.79% (+0.08%)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
2% less funds holding
Funds holding: 47 → 46 (-1)
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$7.28M |
| 2 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$2.59M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$2.4M |
| 4 |
CAM
Connacht Asset Management
New York
|
+$2.09M |
| 5 |
BlackRock
New York
|
+$2.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.14M |
| 2 |
Millennium Management
New York
|
-$1.8M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.46M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.29M |
| 5 |
Squarepoint
New York
|
-$834K |
BDSX Hedge Fund Activity: Q1 2021 in Review
46 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q1 2021, worth a combined $85.6M — up 14% from $75.3M a quarter earlier.
Fund positioning in BDSX was balanced in Q1 2021: 8 funds opened new positions, 8 closed out, 14 added to existing stakes and 16 trimmed.
The largest buyer was Kornitzer Capital Management, opening a new position worth an estimated $7.28M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $2.14M sold.
- 46 institutional investors held Biodesix (BDSX) as of Q1 2021, down from 47 in Q4 2020.
- Funds reported $85.6M of Biodesix stock for Q1 2021, up 14% quarter-over-quarter.
- 8 funds opened new Biodesix positions in Q1 2021 and 8 closed out, a net change of 0 holders.
- The largest Biodesix buyer in Q1 2021 was Kornitzer Capital Management, an estimated $7.28M added.
- The largest Biodesix seller in Q1 2021 was Monashee Investment Management, an estimated $2.14M sold.
Based on aggregated 13F filings for Q1 2021.